CannaPharmaRX announces revocation of cease trade order by BC Securities Commission

CANNAPHARMARX, INC.

BC Securities Commission revoked failure-to-file cease trade order effective December 12, 2025.
Company faces going concern uncertainty with working capital deficiency of $27,009,769 as of Sep 30, 2025.
Related party debt totals $10,762,898 with accrued interest of $3,248,127 as of Sep 30, 2025.
Plans to increase cannabis production at Cremona facility and apply for EU-GMP certification to expand in Germany and Israel.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.